Avantect Pancreatic Cancer Test Enters Patient Enrollment Phase
ClearNote Health and University Hospital Southampton have launched the SAFE-D study to evaluate the Avantect Pancreatic Cancer Test.
Category: Pancreatic
Pancreatic
Latest
Pancreatic
Latest
AI-Powered Technology Provides Early Detection of Pancreatic Cancer
Researchers are leveraging AI to enhance the early detection and treatment of pancreatic cancer, focusing on identifying high-risk cysts.
Pancreatic
Latest
Groundbreaking New Blood Test Offers Early Pancreatic Cancer Diagnosis
Researchers applied targeted mass spectrometry to show that pancreatic cancer arises through changes in cellular metabolism.
Bluestar Genomics Commercializes Pancreatic Cancer Test
Bluestar Genomics has announced its U.S. and international commercialization of a test for early detection of pancreatic cancer.
Read More
New Genetic Culprit Suspected of Pancreatic Cancer Onset
New research points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer.
Read More
Bluestar Genomics’ Pancreatic Cancer Detection Test Achieves High Sensitivity & Specificity
Bluestar Genomics announced the results of a validation study for its early pancreatic cancer detection test. Â
Read More
Pancreatic Cancer Could be Diagnosed up to Three Years Earlier
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests.
Read More
Bluestar Genomics Receives CAP Accreditation for its Clinical Lab
The CAP certification enables Bluestar to serve physicians as it works towards broad commercialization of its pancreatic cancer test.Â
Read More
PancreaSeq Molecular Test Outperforms Current Guidelines
The PancreaSeq molecular test accurately classifies pancreatic cysts as potentially cancerous or benign, a large, multi-center study found.
Read More
Personalis & BC Cancer Assess Benefits of ctDNA for Colorectal, Pancreatic Cancers
Personalis and BC Cancer will deploy a personalized liquid biopsy-based assay for a study of patients with colorectal and pancreatic cancers.
Read More
Researchers Discover Molecular Switch in Pancreatic Cancer that Triggers Metastasis
Pancreatic ductal adenocarcinoma affects more than 90% of patients with pancreatic cancer and has an average 5-year survival rate under 10%.
Read More
Stool Sample Microorganisms Could Help Detect Pancreatic Cancer Early
Researchers have found a molecular signature in stool samples that could predict whether patients are at high risk of pancreatic cancer.
Read More
Researchers May Have Found Diagnostic Game Changer for Pancreatic Cancer
Yale Cancer Center early detection research is providing new reason for optimism for the diagnosis of pancreatic cancer.
Read More
Liquid Biopsy Test Detects Pancreatic Cancer Signal
Bluestar Genomics’ liquid biopsy test can detect a pancreatic cancer signal in people across various age groups and in patients with new-onset diabetes.
Read More
Blood Test May Be Future of Pancreatic Cancer Detection
New research showed that blood tests may be the future of pancreatic cancer detection. Pancreatic cancer is one of the most deadly forms of the disease.
Read More
New Genetic Targets Could Revolutionize Early Pancreatic Cancer Detection
Researchers from Johns Hopkins and an international team, have identified promising new targets for pancreatic cancer treatment and early diagnosis.
Read More
Study: PTX3 Biomarker Could Aid in Pancreatic Cancer Diagnosis
Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer.
Read More
Pancreatic Cancer Action Network Increases Biomarker-Driven Clinical Trial Matching by Nearly 300% with GenomOncology
PanCAN has chosen to upgrade to GenomOncology’s Precision Decision to further enhance the free clinical trial matching services it offers to pancreatic cancer patients.
Read More